Treatment
-
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
-
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
-
Immunotherapy for Early-stage Gastric Cancer‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.
by Laura Gesualdi Gilmore
-
Forward Look
Pro Tips on PROsBreast surgeon Maria Margarete Karsten discusses how using patient-reported outcomes can improve quality of life.
by Ashley P. Taylor
-
A Stronger DefenseResearchers explore the potential of immune checkpoint inhibitors before surgery to prevent recurrence in several cancers.
by Kendall K. Morgan
-
Another Option for Metastatic Prostate CancerPSMA-targeted therapy, which delivers radiation directly to cancer cells, provides a new approach for those whose prostate cancer stops responding to other treatments.
by Stephen Ornes
-
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
-
AACR Annual Meeting 2025Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
-
Researchers Tackle Immune-related Adverse EffectsScientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
-
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
